Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Cohort Study Assessing Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis

NCT03585946 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03585946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03585946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Cohort Study Assessing Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Withdrawn
Start date
January 1, 2030
Completion date
December 31, 2040
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

drug reaction, stevens-johnson syndrome, toxic epidermal necrolysis